Inogen 8-K: Leadership Changes & Compensation Disclosed
Ticker: INGN · Form: 8-K · Filed: Jan 24, 2024 · CIK: 1294133
| Field | Detail |
|---|---|
| Company | Inogen Inc (INGN) |
| Form Type | 8-K |
| Filed Date | Jan 24, 2024 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.001, $425,000, $100,000 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: leadership-change, executive-compensation, corporate-governance
TL;DR
**Inogen just filed an 8-K about leadership changes and compensation, keep an eye on executive shifts.**
AI Summary
Inogen Inc. filed an 8-K on January 24, 2024, reporting that the earliest event occurred on January 21, 2024. This filing is primarily about changes in directors or officers and their compensation, as well as Regulation FD disclosure. For investors, this matters because changes in leadership and executive compensation can signal shifts in company strategy or financial health, potentially impacting future stock performance.
Why It Matters
Changes in executive leadership and compensation can indicate strategic shifts or financial adjustments within Inogen, directly influencing investor confidence and the company's future direction.
Risk Assessment
Risk Level: medium — Changes in leadership can introduce uncertainty, but the specific details of the changes are not fully disclosed in this summary, making the risk moderate.
Analyst Insight
A smart investor would monitor Inogen's subsequent filings or press releases for specific details regarding the leadership changes and compensation arrangements to understand their potential impact on the company's strategy and financial outlook.
Key Players & Entities
- Inogen Inc. (company) — the registrant filing the 8-K
- January 21, 2024 (date) — date of the earliest event reported in the 8-K
- January 24, 2024 (date) — date the 8-K was filed
- 001-36309 (other) — Commission File Number for Inogen Inc.
- INGN (other) — Trading Symbol for Inogen Inc. Common Stock
- The Nasdaq Stock Market LLC (other) — exchange where Inogen Inc. Common Stock is registered
FAQ
What is the primary purpose of this 8-K filing by Inogen Inc.?
The primary purpose of this 8-K filing is to report on the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' and 'Regulation FD Disclosure', as stated in the Item Information section.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 21, 2024, as indicated by 'Date of Report (Date of earliest event reported): January 21, 2024'.
What is Inogen Inc.'s trading symbol and where is its common stock registered?
Inogen Inc.'s trading symbol is INGN, and its Common Stock, $0.001 par value, is registered on The Nasdaq Stock Market LLC.
What is the business address of Inogen Inc.?
The business address of Inogen Inc. is 859 Ward Drive, Goleta, California, 93111, with a business phone number of (805) 562-0500.
Under which SEC Act is this Form 8-K filed?
This Form 8-K is filed under the 1934 Act, as specified in the 'SEC ACT: 1934 Act' section of the filing values.
Filing Stats: 1,673 words · 7 min read · ~6 pages · Grade level 13 · Accepted 2024-01-24 16:05:14
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value INGN The Nasdaq Stock Mar
- $425,000 — e will receive an annual base salary of $425,000 and a target annual performance bonus o
- $100,000 — so provides for a cash sign-on bonus of $100,000, which is repayable on a pro-rata basis
Filing Documents
- ingn-20240121.htm (8-K) — 52KB
- ingn-ex10_1.htm (EX-10.1) — 120KB
- ingn-ex99_1.htm (EX-99.1) — 15KB
- img132417817_0.jpg (GRAPHIC) — 3KB
- img132417817_1.jpg (GRAPHIC) — 3KB
- 0000950170-24-006969.txt ( ) — 336KB
- ingn-20240121.xsd (EX-101.SCH) — 24KB
- ingn-20240121_htm.xml (XML) — 5KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On January 24, 2024, the Company issued a press release announcing the appointment and transition described in this Current Report on Form 8-K. A copy of the press release is furnished herewith as Exhibit 99.1. The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. d) Exhibits Exhibit Description 10.1 Employment and Severance Agreement by and between the Company and Michael Bourque, dated effective as March 4, 2024 99.1 Press Release dated January 24, 2024 104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. INOGEN, INC. Date: January 24, 2024 By: /s/ Michael Sergesketter Michael Sergesketter Interim Chief Financial Officer (Principal Accounting and Financial Officer)